Salmeterol/Fluticasone Neutec 50 mikrogram/500 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone neutec 50 mikrogram/500 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/500 mikrogram/dos - salmeterolxinafoat 73 mikrog aktiv substans; laktosmonohydrat hjälpämne; flutikasonpropionat 500 mikrog aktiv substans

Campona Airmaster 50 mikrogram/500 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

campona airmaster 50 mikrogram/500 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/500 mikrogram/dos - salmeterolxinafoat 73 mikrog aktiv substans; laktosmonohydrat hjälpämne; flutikasonpropionat 500 mikrog aktiv substans

Neuair Airmaster 50 mikrogram/500 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

neuair airmaster 50 mikrogram/500 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/500 mikrogram/dos - flutikasonpropionat 500 mikrog aktiv substans; laktosmonohydrat hjälpämne; salmeterolxinafoat 73 mikrog aktiv substans

Sipova Airmaster 50 mikrogram/250 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sipova airmaster 50 mikrogram/250 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/250 mikrogram/dos - flutikasonpropionat 250 mikrog aktiv substans; laktosmonohydrat hjälpämne; salmeterolxinafoat 73 mikrog aktiv substans

Sipova Airmaster 50 mikrogram/100 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sipova airmaster 50 mikrogram/100 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/100 mikrogram/dos - salmeterolxinafoat 73 mikrog aktiv substans; flutikasonpropionat 100 mikrog aktiv substans; laktosmonohydrat hjälpämne

Sipova Airmaster 50 mikrogram/500 mikrogram/dos Inhalationspulver, avdelad dos Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sipova airmaster 50 mikrogram/500 mikrogram/dos inhalationspulver, avdelad dos

neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/500 mikrogram/dos - laktosmonohydrat hjälpämne; flutikasonpropionat 500 mikrog aktiv substans; salmeterolxinafoat 73 mikrog aktiv substans

Sugammadex Piramal Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulär blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Mylan Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversering av neuromuskulär blockad som induceras av rocuronium eller vekuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.